Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Mar. 26, 2022	Mar. 27, 2021
Operating activities:
Net earnings	$ 14,362,000	$ 7,839,000
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation of fixed assets	23,868,000	24,253,000
Amortization of intangibles and deferred costs	1,183,000	1,457,000
Loss from disposals of property & equipment	100,000	0
Share-based compensation	2,350,000	2,270,000
Deferred income taxes	(251,000)	(4,000)
Loss (Gain) on marketable securities	69,000	(768,000)
Other	(184,000)	(163,000)
Changes in assets and liabilities net of effects from purchase of companies
Increase in accounts receivable	(25,031,000)	(10,884,000)
Increase in inventories	(36,538,000)	(6,432,000)
Increase in prepaid expenses	(4,308,000)	(118,000)
(Decrease) increase in accounts payable and accrued liabilities	(2,055,000)	9,331,000
Net cash (used in) provided by operating activities	(26,435,000)	26,781,000
Investing activities:
Purchases of property, plant and equipment	(35,306,000)	(18,829,000)
Proceeds from redemption and sales of marketable securities	11,526,000	41,337,000
Proceeds from disposal of property and equipment	589,000	1,262,000
Other	0	18,000
Net cash (used in) provided by investing activities	(23,191,000)	23,788,000
Financing activities:
Proceeds from issuance of stock	11,741,000	13,582,000
Payments on finance lease obligations	(111,000)	(173,000)
Payment of cash dividend	(24,163,000)	(21,776,000)
Net cash used in financing activities	(12,533,000)	(8,367,000)
Effect of exchange rate on cash and cash equivalents	(16,000)	375,000
Net (decrease) increase in cash and cash equivalents	(62,175,000)	42,577,000
Cash and cash equivalents at beginning of period	283,192,000	195,809,000
Cash and cash equivalents at end of period	$ 221,017,000	$ 238,386,000